Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Azit | 2024 | Venture - Series Unknown | Undisclosed | Tokyo |
| SteelEye | 2022 | Series B | $21.0M | London |
| Elucidata | 2022 | Series A | $16.0M | Cambridge |
| SenseOn | 2021 | Series A | $20.0M | London |
| StashAway | 2022 | Series D | $12.7M | Singapore |
| Pony.ai | 2025 | Corporate Round | $12.9M | Fremont |
| Canoe | 2024 | Series C | $36.0M | New York |
| ProcessOn | 2022 | Series A | $13.3M | Kowloon City |
| Castor | 2021 | Series B | $45.0M | Amsterdam |
| CareStack | 2022 | Corporate Round | Undisclosed | Kissimmee |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Azit | Venture - Series Unknown | Undisclosed | Tokyo, Japan |
| 2 | SteelEye | Series B | $21.0M | London, United Kingdom |
| 3 | Elucidata | Series A | $16.0M | Cambridge, United States |
| 4 | SenseOn | Series A | $20.0M | London, United Kingdom |
| 5 | StashAway | Series D | $12.7M | Singapore, Singapore |
| 6 | Pony.ai | Corporate Round | $12.9M | Fremont, United States |
| 7 | Canoe | Series C | $36.0M | New York, United States |
| 8 | ProcessOn | Series A | $13.3M | Kowloon City, Hong Kong |
| 9 | Castor | Series B | $45.0M | Amsterdam, The Netherlands |
| 10 | CareStack | Corporate Round | Undisclosed | Kissimmee, United States |
Azit is a mobility solution provider that provides digital transformation platform and transportation management system services.
SteelEye develops a holistic compliance platform for record keeping, surveillance, and intelligent insights.
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
SenseOn provides accurate and context-rich alerts.
StashAway is a wealth management platform that delivers personalized portfolio management to both retail and accredited investors.
Pony.ai develops autonomous driving technology for vehicles that operates using artificial intelligence and machine learning.
Canoe develops an AI technology to help alternative investment firms streamline their data management processes.
ProcessOn is a collaborative drawing platform that allows users to easily create a variety of diagrams such as mindmaps and flowcharts.
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
CareStack is a practice management platform for dental groups to manage all of their software and daily operations through one platform.
NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.
K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.
Gloat is a Workforce Agility Operating System helping put people and businesses in motion
SDP Japan is a procurement and sales of surgical components, pharmaceuticals, and consumables.
Aden Financial is a cross-border OTC assets E-trading platform.
Patient 21 is a healthtech company that aims to empower patients and doctors to make better decisions by leveraging data.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Reveal is the free platform for Partnership, Marketing, and Sales teams to generate revenue through their ecosystem.
InsightFinder specializes in AI-powered observability and predictive analytics for IT operations.
JIFFY.ai helps wealth firms boost productivity, enhance client engagement, and streamline onboarding, servicing & data management with AI.
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
HiLabs is a Data Analytics Platform.
Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.
Eight Roads Ventures has invested in 181 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eight Roads Ventures's top investment sectors include Software, Artificial Intelligence (AI), Health Care, SaaS, Biotechnology. The firm invests across 49 different industry categories.
Among tracked funding rounds, Engrail Therapeutics received $167.0M in a Series B round. Eight Roads Ventures's total known invested capital is $4.4B.
Eight Roads Ventures's average investment size is $35.4M across its portfolio of 181 companies.
Recent Eight Roads Ventures portfolio additions include Azit, SteelEye, Elucidata, SenseOn, StashAway. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors